Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? [Yahoo! Finance]
Instil Bio, Inc. (TIL)
NASDAQ:AMEX Investor Relations:
nasdaq.com/symbol/til
Company Research
Source: Yahoo! Finance
If you're an investor looking for stocks that can make dramatic gains in a short amount of time, you may have noticed a small-cap biopharmaceutical company called Instil Bio (NASDAQ: TIL) has been rocketing higher. From Sept. 6 through Sept. 12, shares of the clinical-stage drugmaker shot about 235% higher. A big week raised its year-to-date gain to an eye-popping 510%, and investors are wondering if it can climb higher still. Here's a quick look at what's been pushing up shares of Instil Bio and some of its challenges. Plus, I'll also measure the good news against the bad to see if everyday investors can reasonably expect this stock to continue climbing. Why Instil Bio stock is soaring At the beginning of 2024, Instil Bio was still trying to develop cell-based cancer therapies that rely on tumor-infiltrating lymphocytes, or TILs. In August, the company switched gears and in-licensed IMM2510, a bispecific antibody that targets programmed death ligand 1 (PD-L1) and vascular en
Show less
Read more
Impact Snapshot
Event Time:
TIL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TIL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TIL alerts
High impacting Instil Bio, Inc. news events
Weekly update
A roundup of the hottest topics
TIL
News
- BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up [Yahoo! Finance]Yahoo! Finance
- Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewswire
- Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast CancerGlobeNewswire
- Summit boosts Instil, BioNTech as lead drug beats Merck's Keytruda [Seeking Alpha]Seeking Alpha
- Futures Gain As Expectations For A 50bps Rate Cut Spike [zero hedge]zero hedge
TIL
Earnings
- 11/13/24 - Miss
TIL
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/13/24 - Form S-3
- TIL's page on the SEC website